1. 7th International Immunoglobulin Conference: Foreword. (December 2014) Authors: Jolles, S.; Jordan, S. C.; Orange, J. S.; van Schaik, I. N. Journal: Clinical and experimental immunology Issue: Volume 178(2014)supplement 1 Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A UK national audit of hereditary and acquired angioedema. (January 2014) Authors: Jolles, S.; Williams, P.; Carne, E.; Mian, H.; Huissoon, A.; Wong, G.; Hackett, S.; Lortan, J.; Platts, V.; Longhurst, H.; Grigoriadou, S.; Dempster, J.; Deacock, S.; Khan, S.; Darroch, J.; Simon, C.; Thomas, M.; Pavaladurai, V.; Alachkar, H.; Herwadkar, A. Journal: Clinical and experimental immunology Issue: Volume 175:Number 1(2014:Jan.) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders. (7th March 2019) Authors: Bethune, C.; Egner, W.; Garcez, T.; Huissoon, A.; Jolles, S.; Karim, Y.; Jain, R.; Savic, S.; Kelley, K.; Grosse‐Kreul, D.; Grigoriadou, S. Journal: Clinical and experimental immunology Issue: Volume 196:Number 3(2019) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. C1 inhibitor deficiency: 2014 United Kingdom consensus document. (13th May 2015) Authors: Longhurst, H. J.; Tarzi, M. D.; Ashworth, F.; Bethune, C.; Cale, C.; Dempster, J.; Gompels, M.; Jolles, S.; Seneviratne, S.; Symons, C.; Price, A.; Edgar, D. Journal: Clinical and experimental immunology Issue: Volume 180:Number 3(2015:Jun.) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Calculated globulin (CG) as a screening test for antibody deficiency. (September 2014) Authors: Jolles, S.; Borrell, R.; Zouwail, S.; Heaps, A.; Sharp, H.; Moody, M.; Selwood, C.; Williams, P.; Phillips, C.; Hood, K.; Holding, S.; El Shanawany, T. Journal: Clinical and experimental immunology Issue: Volume 177:Number 3(2014:Sep.) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia. (27th January 2016) Authors: Brent, J.; Guzman, D.; Bangs, C.; Grimbacher, B.; Fayolle, C.; Huissoon, A.; Bethune, C.; Thomas, M.; Patel, S.; Jolles, S.; Alachkar, H.; Kumaratne, D.; Baxendale, H.; Edgar, J. D.; Helbert, M.; Hambleton, S.; Arkwright, P. D. Journal: Clinical and experimental immunology Issue: Volume 184:Number 1(2016:Apr.) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical and laboratory features of seventy‐eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia). (21st October 2018) Authors: Zaman, M.; Huissoon, A.; Buckland, M.; Patel, S.; Alachkar, H.; Edgar, J. D.; Thomas, M.; Arumugakani, G.; Baxendale, H.; Burns, S.; Williams, A. P.; Jolles, S.; Herriot, R.; Sargur, R. B.; Arkwright, P. D. Journal: Clinical and experimental immunology Issue: Volume 195:Number 1(2019) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease1. (February 2015) Authors: Jolles, S.; Orange, J. S.; Gardulf, A.; Stein, M. R.; Shapiro, R.; Borte, M.; Berger, M. Journal: Clinical and experimental immunology Issue: Volume 179:Number 2(2015:Feb.) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study. (May 2023) Authors: Snooks, H.; Watkins, A.; Lyons, J.; Akbari, A.; Bailey, R.; Bethell, L.; Carson-Stevens, A.; Edwards, A.; Emery, H.; Evans, B.A.; Jolles, S.; John, A.; Kingston, M.; Porter, A.; Sewell, B.; Williams, V.; Lyons, R.A. Journal: Public health Issue: Volume 218(2023) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies. (18th October 2016) Authors: Borte, M.; Kriván, G.; Derfalvi, B.; Maródi, L.; Harrer, T.; Jolles, S.; Bourgeois, C.; Engl, W.; Leibl, H.; McCoy, B.; Gelmont, D.; Yel, L. Other Names: Weinberger Birgit guestEditor.; Akbar Arne guestEditor. Journal: Clinical and experimental immunology Issue: Volume 187:Number 1(2017:Jan.) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗